Merck to Present New Data on Daily, Weekly, and Monthly Options Across its HIV Treatment and Prevention Pipeline at AIDS 2026

Go back to Merck to Present New Data on Daily, Weekly, and Monthly Options Across its HIV Treatment and Prevention Pipeline at AIDS 2026
Merck & Co. (NYSE: MRK) Delayed: 130.42 -0.5 (0.38%)
Previous Close $130.92    52 Week High $65.46 
Open $129.93    52 Week Low $47.97 
Day High $132.84    P/E 88.72 
Day Low $129.70    EPS $1.47 
Volume 6,343,840